IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular Revenue and Competitors
Estimated Revenue & Valuation
- IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular's estimated annual revenue is currently $12.6M per year.
- IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular's estimated revenue per employee is $251,000
Employee Data
- IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular has 50 Employees.
- IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular grew their employee count by 4% last year.
IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular's People
Name | Title | Email/Phone |
---|
IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.6M | 74 | 21% | N/A | N/A |
#2 | $37.7M | 150 | -7% | N/A | N/A |
#3 | $1.4M | 11 | -31% | $5.1M | N/A |
#4 | $49.7M | 198 | 14% | N/A | N/A |
#5 | $1.3M | 10 | 0% | $6.3M | N/A |
#6 | $60.7M | 242 | N/A | N/A | N/A |
#7 | $28.1M | 112 | 8% | N/A | N/A |
#8 | $5.5M | 22 | -19% | N/A | N/A |
#9 | $3M | 12 | -20% | N/A | N/A |
#10 | $10.3M | 41 | N/A | N/A | N/A |
What Is IDEVÂ Technologies Inc. - a wholly owned subsidiary of Abbott Vascular?
IDEV is an innovator and developer of next generation medical devices for use in interventional radiology, vascular surgery, and cardiology. The SurePath Guidewire is available in the United States for PTA/PTCA and available in Europe for PTA. The Supera Peripheral Stent System is currently sold throughout the United States, Europe, Asia and Canada.
keywords:N/AN/A
Total Funding
50
Number of Employees
$12.6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.6M | 50 | -7% | N/A |
#2 | $13.6M | 52 | 13% | N/A |
#3 | $17.5M | 55 | -14% | N/A |
#4 | $7.5M | 56 | 8% | N/A |
#5 | $5M | 56 | 10% | N/A |